Congress Must Clarify FDA Oversight On Compounding: GAO
Lawmakers must resolve the lingering uncertainty about what oversight authority the U.S. Food and Drug Administration has over the controversial drug compounding industry in the wake of a fatal meningitis outbreak...To view the full article, register now.
Already a subscriber? Click here to view full article